Delivery Order SPE2DB20D3104-SPE2DB24FV9T5

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.81 Firm Fixed Price delivery order is for the supply of Mucinex D ER 600-60 mg tablets to support military healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This is a contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,692.75 firm-fixed-price delivery order is for the supply of Mucinex D ER 600-60 mg tablets. The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.69 firm fixed-price delivery order is for the supply of Mucinex D ER 600-60 mg tablets, which will be delivered by February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, that serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,379.05 firm-fixed-price delivery order covers the supply of MUCINEX D ER 600-60 MG TABLET 18S, a pharmaceutical product, with a period of performance through February 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MUCINEX D ER 600-60 MG TABLET 18S. The award has a ceiling value of $1,197.49 and an ultimate completion date of September 18, 2024. The contract has no set-aside designation. This delivery order is likely part of a larger indefinite delivery contract (IDC) vehicle held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,006.28 firm fixed-price delivery order is for the supply of Mucinex D ER 600-60 mg tablets. The contract has an ultimate completion date of April 21, 2023 and was awarded on April 20, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,437.76, is for the delivery of Mucinex D ER 600-60 mg Tablets. The contract is a firm fixed-price delivery order with a completion date of February 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,185.76 firm fixed-price delivery order is for the supply of MUCINEX D ER 600-60 MG TABLET 18S, a pharmaceutical product, with a performance period through May 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mucinex D ER 600-60 MG Tablet 36S. The contract, valued at $3,345.99, is a firm fixed-price delivery order with a completion date of August 26, 2024. The contract is not set aside and is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mucinex D ER 600-60 mg tablets. The contract has a ceiling value of $1,338.60 and a completion date of June 12, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV9T5
    Delivery Order

This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,176.80 firm fixed-price delivery order is for the supply of Mucinex D ER 600-60 mg Tablets in quantities of 18 per package. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order is intended to fulfill the medical product needs of military treatment facilities, veterans' healthcare programs, and other federal medical institutions served by the DLA.

Generated 2/27/25, 11:14 AM